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Abstract
Whether oxygen should be administered acutely during ST-segment elevation myocardial infarction is debated. Despite this controversy, the
possible influence of supplementary oxygen on animal models of ischaemia–reperfusion injury or cardioprotection is rarely considered. We
used an in vivo mouse model of ischaemia and reperfusion to investigate the effect of ventilation with room air versus 100% oxygen. The coro-
nary artery of anaesthetized mice was occluded for 40 min. followed by 2-hrs reperfusion. Infarct size was measured by tetrazolium staining
and expressed as a percentage of area at risk, determined using Evan’s blue. Unexpectedly, infarct size in mice ventilated with 100% oxygen
was significantly smaller than in those ventilated with room air (33  5% versus 46  3%; n = 6; P < 0.01). We tested a standard protocol of
3 9 5 min. cycles of remote ischaemic preconditioning (RIPC) and found this was unable to protect mice ventilated with 100% oxygen. RIPC
protocols using 2.5- or 10-min. occlusion were similarly ineffective in mice ventilated with oxygen. Similar disparate results were obtained with
direct cardiac ischaemic preconditioning. In contrast, pharmacological protection using bradykinin administered at reperfusion was effective
even in mice ventilated with 100% oxygen, reducing infarct size from 33  5% to 21  3% (n = 4–6; P < 0.01). Laser speckle contrast imag-
ing of blood flow and direct pO2 measurements were made in the hindlimb, but these measurements did not correlate with protection. In con-
clusion, ventilation protocol can have a major influence on infarct size and ischaemic preconditioning protocols in mice.
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Introduction
Oxygen is often administered to patients experiencing uncomplicated
ST-segment elevation myocardial infarction (STEMI). However,
whether it is beneficial in this context remains controversial [1, 2].
Remote ischaemic pre- and post-conditioning (RIC) has been investi-
gated as a method of protecting the myocardium against ischaemia
and reperfusion injury that occurs during STEMI treated by primary
percutaneous coronary intervention or during cardiac surgery [3, 4].
Despite initial promise in the setting of coronary artery bypass graft
(CABG) surgery, the outcomes of two recent large clinical trials were
neutral [5, 6]. Pilot studies of RIC in the setting of STEMI have shown
more consistent benefit and large clinical trials are currently under-
way [7]. However, it is important to recognize that although a number
of factors have been proposed to influence the efficacy of RIC, few of
these have been systematically examined in either the clinical or
experimental setting. This fact is highlighted by a recent meta-analy-
sis that demonstrated a strong, consistent beneficial effect of RIC in
reducing infarct size in in vivo animal experiments of ischaemia and
reperfusion injury, but was unable to identify experimental variables
that significantly contributed to the observed large experimental
heterogeneity [8]. In this meta-analysis, the variable most strongly
related to the degree of protection by RIPC (albeit not reaching signif-
icance), was the oxygenation status, that is to say whether animals
were ventilated with room air or with high-flow supplemental oxygen
[8]. This led us to hypothesize that RIPC in animal experiments might
be affected by supplemental oxygen because limb pO2 takes longer to
reach a sufficient hypoxic threshold for cardioprotection, a variable
which has not been considered previously in such experiments.
To investigate the effect of ventilation strategy on RIPC in the
experimental setting, and whether the duration of limb ischaemia is
an important variable in the development of RIPC, we performed a set
of infarction experiments in mice. In parallel, we measured limb pO2
during the RIPC procedure using a phosphorescent pO2 probe, as
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well as blood flow by laser speckle contrast imaging. These experi-
ments revealed a number of unexpected observations which we
believe are useful in understanding the role of ischaemic time and
oxygenation in RIPC protocols in mice.
Materials and methods
All animals received humane care in accordance with the United King-
dom Home Office Guide on the Operation of Animal (Scientific Proce-
dures) Act of 1986. The investigation conforms to the guidelines from
Directive 2010/63/EU of the European Parliament on the protection of
animals used for scientific purposes or the NIH guidelines. All experi-
ments approved by the appropriate ethics committee and have therefore
been performed in accordance with the ethical standards laid down in
the 1964 Declaration of Helsinki and its later amendments.
C57Bl/6 mice were anaesthetized by i.p. injection of 80 mg/kg pento-
barbitone at a concentration of 20 mg/ml in 0.9% (w/v) saline and
maintained at 36.5  0.5°C on a heating mat. Surgery was started once
pedal and tail reflexes were abolished and depth of anaesthesia was
monitored throughout. Mice were intubated using a 19G cannula and
ventilated using a MiniVent, type 845, Small Animal Ventilator (Harvard
Apparatus, Kent, UK), supplemented with either room air or 100% oxy-
gen, at a flow rate of 1.0 l/min. with 2 cmH2O PEEP, stroke volume
200 ll at 130 strokes/min. The left anterior descending (LAD) coronary
artery then was occluded (verified by ST elevation, hypokinesia and pal-
lor) for 40 min. followed by 2 hrs reperfusion, after which infarct size
was measured by tetrazolium staining and expressed as a percentage of
area at risk, determined using Evan’s blue. A total of 82 mice were used
for infarct experiments and were randomly assigned to treatment group.
Seven mice died during reperfusion and were excluded from analyses
(two control, one 5-min. RIPC, two 10-min. RIPC, one vehicle, one bra-
dykinin).
RIPC was induced using a 6-mm lumen custom vascular occluder
(Kent Scientific, Torrington, CT, USA) around the right hindlimb inflated
to 250 mmHg to induce three cycles of 2.5-, 5- or 10-min. ischaemia,
followed by 5-min. reperfusion after each cycle (Fig. 1). Classical, ‘di-
rect’ ischaemic preconditioning (IPC) was induced by one cycle of 5-
min. LAD occlusion and 5-min. reperfusion. Pharmacological precondi-
tioning using bradykinin was administered by slow injection via the
external jugular vein at 40 lg/kg in a vehicle of 0.1 mM acetic acid in
saline, prior to index ischaemia. Vehicle control mice received 0.1 mM
acetic acid in saline. Animals were killed by severing of the aorta.
Blood flow was visualized in the hindlimb during RIPC using a FLPI-2
laser speckle contrast blood flow imager (Moor Instruments, Axminster,
United Kingdom), which delivers images at high time and spatial resolu-
tion. Hair was first removed from both hindlimbs using Veet depilation.
Full-frame images were recorded at 5 Hz and then subsequently analysed
by averaging the image intensity over an area of interest encompassing
the entire exposed upper limb. Similar results were obtained if a region
containing only the femoral artery or only smaller vessels was used.
Limb muscle pO2 was measured every 5 sec. using a bare-fibre
phosphorescent sensor connected to an OxyliteTM monitor (Oxford
Optronix, Abingdon, United Kingdom). The probe was pre-coated with a
10 U/ml solution of heparin in saline to prevent haematoma, then slowly
inserted into the vastus intermedius muscle along the track of a punc-
ture made using a 21G 9 5/8” Microlance needle to a depth of 5 mm.
tPO2 measurements were continuously recorded using PowerLab 4/25
coupled to Chart 7 (AD Instruments, Oxon, UK).
The results are shown as mean  standard deviation of the mean.
Statistical comparison of the groups was made by two-way ANOVA, with
Bonferroni correction for multiple comparisons. A significance value of
P < 0.05 was considered significant.
Results
Mice ventilated with either room air or 100% O2 were subject to 40-
min. coronary ischaemia followed by 120-min. reperfusion, after
which the ischaemic area at risk and infarct area were measured. IPC
was applied directly to the heart for 5 min. or remotely to the hin-
dlimb for three cycles of 2.5-, 5- or 10-min. ischaemia separated by
5-min. reperfusion (Fig. 1). Bradykinin (40 lg/kg) was injected i.v. as
a positive control for a pharmacological preconditioning mimetic that
does not depend on hypoxia to induce cardioprotection. The area at
risk was similar in all groups (Fig. 2A) (see Fig. S2 for representative
images of TTC-stained heart slices).
Infarct size was significantly smaller in mice breathing O2 com-
pared to those breathing room air (P < 0.01 for an effect of ventila-
tion method by two-way ANOVA, P < 0.05 when comparing control
groups only by Bonferroni correction) (Fig. 2B). RIPC induced using
either 2.5- or 5-min. cycles was cardioprotective in mice breathing
room air, but not supplementary O2 (Fig. 2B). An RIPC protocol using
a longer cycle time of 10 min. was ineffective under both ventilation
strategies (Fig. 2B). Reasoning that supplementary O2 may interfere
Fig. 1 Experimental protocols. All mice were subject to 40-min. coronary artery ligation followed by reperfusion for 120 min. in vivo. Preconditioning
periods of ischaemia were applied either directly to the heart (‘classical’ IPC) or remotely, by inflation of a cuff on the limb (RIPC), and are indicated
in red. 40 lg/kg bradykinin was administered i.v. 5 min. before ischaemia (blue).
2 ª 2017 The Authors.
Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.
with the induction of hypoxia/ischaemia in the limb, we tested direct
cardiac ‘IPC’ and found that this was able to reduce infarct size in
room air, but was similarly ineffective under O2 (Fig. 2B). In contrast,
pharmacological protection using bradykinin was able to reduce
infarct size in both settings (Fig. 2B).
Heart rate was measured at selected time-points during the exper-
iment. There was a small but significant decrease in heart rate over
the course of the experiment (P < 0.01), but there were no significant
effects of treatment on heart rate over this time period (Fig. S1).
When analysing individual time-points, heart rate at baseline (mea-
sured 5 min. before ischaemia) was slightly elevated (P < 0.05) in
the mice breathing O2 that had been treated with bradykinin, as antici-
pated. The only other time-point to show a significant difference was
the 15-min. time-point, when heart rate was lower in the RIPC
2.5 min. group on room air. On average, the heart rate in all mice
receiving oxygen was consistently lower at each time-point than the
heart rate of those breathing room air at all time periods, averaging
6.0  1.6 bpm lower, although this was not statistically significant
by two-way ANOVA (P = 0.31).
We hypothesized that ventilation with supplementary oxygen
might alter peripheral vasomotor tone, thereby affecting reactive
hyperaemia, which is believed to be involved in the mechanism of
RIPC [9]. For these and subsequent experiments, we focussed on 5-
versus 10-min. limb ischaemia, with ventilation by either room air or
supplementary O2. Laser speckle contrast tissue imaging was used to
measure blood flow in the limb with high sampling frequency. Static
images illustrate the complete cessation of blood flow in the ischae-
mic limb during RIPC and hyperaemia following reperfusion (Fig. 3A
and B). We measured the degree of reactive hyperaemia during the
three reperfusion phases of RIPC. As the response was virtually iden-
tical in each of the three cycles, these were averaged together for
each mouse (Fig. 3B and C). The peak hyperaemic response was
significantly higher after 10-min. occlusion than after 5 min.
(P = 0.05), but was not affected by ventilation protocol (Fig. 3C and
D). Similarly, the length of time required for the blood flow to return
to baseline (that is, 100% flow) was longer after 10-min. occlusion
than 5 min., but this was similarly unaffected by ventilation protocol
(Fig. 3C and E). In separate mice, changing ventilation from air to O2
did not significantly alter hindlimb blood flow (N = 3, P = 0.25).
Blood flow was also measured in the non-preconditioned limb and
was found to increase by 8.8  1.1% after release of the cuff, sug-
gesting a systemic response; however, this was not significantly dif-
ferent in any of the groups (data not shown).
To test the hypothesis that supplementary oxygen affected the
time taken to achieve muscle hypoxia, we measured limb pO2 with a
fine, phosphorescent tissue sensor. The average traces of pO2 over
time demonstrate that basal muscle pO2 was slightly elevated in mice
ventilated with supplementary oxygen (red traces, Fig. 4A). pO2
rapidly decreased to <1 mmHg within a minute of limb occlusion,
and this drop was very similar in mice breathing room air and supple-
mentary oxygen. After reperfusion, pO2 increased rapidly, exhibiting a
hyperaemic overshoot which was much greater in mice breathing
supplementary oxygen (Fig. 4A and B). Thus, the total time during
which tissue was hypoxic was not altered by different ventilation
strategies. Interestingly, after the cuff was deflated, pO2 returned to
baseline ~10 times more slowly (30–75 sec.) than blood flow
returned to baseline (3–7 sec., data not shown).
Discussion
In these studies, we set out to determine whether supplemental oxy-
gen would affect infarct size in mice subject to ischaemia and reperfu-
sion. In two separate groups of mice (control and vehicle), ventilation
Fig. 2 Infarct size after ischaemia and
reperfusion compared in mice ventilated
with room air or supplemental O2. The
effectiveness of preconditioning protocols
was affected by ventilation. (A) Area at
risk expressed as a percentage of the left
ventricle. N number indicated in white. (B)
Area of infarct expressed as a percentage
of the area at risk. N number indicated in
white. By two-way ANOVA, there was a sig-
nificant effect of oxygenation (P < 0.01),
treatment (P < 0.001) and interaction
(P < 0.001). **P < 0.01 ***P < 0.001
compared to relevant controls. †P < 0.05
compared to room air control.
ª 2017 The Authors.
Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.
3
J. Cell. Mol. Med. Vol XX, No X, 2017
with supplemental oxygen was found to reduce infarct size. Further-
more, a standard protocol of three cycles of 5-min. RIPC was unable
to induce further protection. This was not because the mice were at a
‘ceiling’ of cardioprotection because the pharmacological precondi-
tioning agent, bradykinin, was able to induce additional cardioprotec-
tion. Longer or shorter periods of limb ischaemia were similarly
ineffective at inducing RIPC in supplemental oxygen, as was direct
cardiac IPC, despite it being effective in room air. These results led us
to hypothesize that alterations in limb oxygenation or in the restora-
tion of limb blood flow during the reperfusion phase (perhaps
secondary to peripheral vasoconstriction) could explain the inability
to induce protection. This possibility was supported by the observa-
tion that cycles of RIPC with 10-min. ischaemia duration were ineffec-
tive at inducing cardioprotection even in room air, which might
suggest that limb reperfusion was inadequate after prolonged ischae-
mia. However, when blood perfusion or limb pO2 was directly and
precisely measured by laser speckle contrast imaging and using an
intramuscular pO2 sensor, no alterations in the induction of tissue
hypoxia, total hypoxia duration, or restoration of blood flow and reac-
tive hyperaemia were found that could explain the observations.
Fig. 3 Blood flow (reactive hyperaemia) in
the hindlimb measured by laser speckle
contrast imaging. (A) Colour image of
blood flow in the hindlimb, demonstrating
cessation of blood flow after cuff inflation
(‘ischaemia’), and hyperaemic response
after release (white arrows). (B) Chart of
blood flow in RIPC limb during a repre-
sentative experiment, relative to baseline
of 100%. (C) Average blood flow during
reperfusion phase, averaged over three
phases and n = 3 mice. (D, E) Maximum
increase in blood flow tissue pO2 (mmHg)
(D) and time to recover to baseline (E)
during the reperfusion phase of RIPC. By
two-way ANOVA, RIPC time affected the
increase in blood flow (P < 0.05),
although no differences were significant
by Bonferroni post hoc test. N = 3 mice
per group.
Fig. 4 (A) Average limb tissue pO2
(mmHg) from baseline to the end of the
first reperfusion phase (N = 3 mice per
group). (B) Average limb tissue pO2 at
baseline and the peak during the reperfu-
sion phase of RIPC. Peak and baseline dif-
fered significant by paired two-way ANOVA.
**P < 0.01, ***P < 0.001. N = 3 mice
per group.
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Why are mice ventilated with supplemental O2
protected?
We considered several possible reasons for mice breathing O2 having
smaller infarcts. Higher oxygen saturation can induce cardiac bradycar-
dia [10], and heart rate is known to influence infarct size. However, we
observed no significant effect of ventilation strategy on heart rate. On
average, the heart rate in mice receiving oxygen was 6.0  1.6 bpm
(~1%) less than those receiving room air, but this small difference
seems unlikely to account for the significant protection. A mechanism
involving redistribution of coronary blood flow to the ischaemic region
via coronary collaterals is not possible, because the strain of mice used
here lack significant coronary collateralization [11]. It may be argued
that increased pO2 improves oxygenation of peri-infarct regions via sim-
ple diffusion into the ischaemic periphery, but it must be remembered
that the tissue pO2 gradient in the heart is extremely high due to the
high oxygen consumption rates of cardiomyocyte mitochondria [12].
Transient exposure to hyperoxia lasting at least 120 min. has
been shown to mimic preconditioning, reducing infarct size in rats
subsequently subjected to ischaemia and reperfusion [13], although
the mechanism was not established. In humans, hyperoxia has been
shown to increase parasympathetic influence on the heart [10]. RIPC
is believed to induce cardioprotection via two parallel pathways, one
involving the release of a humoural factor and the other via parasym-
pathetic activation [14–17]. Therefore, parasympathetic activation by
hyperoxia could potentially explain why hearts are protected and not
amenable to further protection by RIPC. In this scenario, bradykinin is
capable of delivering additional cardioprotective benefit via a direct
signalling mechanism.
Hyperoxia also appears to reduce infarct size in other organs. For
example, hyperoxia during cerebral ischaemia in rats has been shown
to slow infarct development as well as decreasing ultimate infarct size
[18–20]. Hyperoxia in this model did not alter cerebral blood flow [18].
Why is ischaemic conditioning ineffective when
breathing supplemental O2?
The explanation for the ineffectiveness of IPC and RIPC in mice
breathing supplemental O2 is unclear. Despite the activation of a pro-
tective mechanism in these mice, there is clearly room for additional
protection, as demonstrated by the use of bradykinin. This suggests
that the inability to induce protection is related either to the inability
to produce sufficient ischaemia under these conditions or to the
inability of ischaemia to activate protective signalling pathways.
Reactive hyperaemia is believed to be important for the induction of
protective signalling pathways by RIPC [9]. As oxygen status can
cause dramatic redistribution of blood flow between the periphery
and central organs [21, 22], we tested that hypothesis that limb per-
fusion or reactive hyperaemia was decreased when ventilated with
oxygen. However, we observed no effect of ventilation strategy on
resting hindlimb blood flow or on the ability to reperfuse the limb, as
demonstrated by a robust hyperaemic response during the
reperfusion phase of RIPC.
RIPC applied to the lower limbs increases coronary blood flow in
pigs [23], and RIPC also transiently increases coronary blood flow in
healthy human beings, via a hyperaemic response during early reper-
fusion [24]. Thus, the hyperaemia of RIPC appears to be a systemic
response. We are unable to measure coronary blood flow in the
mouse but we detected a consistent increase in blood flow in the
non-RIPC limb following the RIPC procedure. Again, however, this
response was unaltered by oxygen status.
How important is the ischaemia duration during
RIPC?
In room air, 2.5- and 5-min. periods of ischaemia during RIPC were
protective, but 10-min. periods were not. Identical results were
observed by Botker’s group using a model in which RIPC was applied
to mice in vivo, before hearts were removed, perfused on a Langen-
dorff apparatus, and infarcted ex vivo [25]. This would suggest that
careful optimization of the ischaemic duration in patients is important.
The reason for loss of protection with 10-min. protocol is not clear.
After 10 min., the vessels of the hindlimb remained patent and limbs
reperfused well – indeed, the hyperaemic response was significantly
greater than after 5 min. Limb pO2 was restored to normal with similar
kinetics after 5- and 10-min. ischaemia. One possibility is that longer
durations of limb ischaemia cause the release of an ‘anti-protective’
factor that counteracts the benefits of RIPC. Extensive further work
would be required to confirm this hypothesis, for example by measur-
ing plasma levels of parameters such as proinflammatory cytokines.
We conclude that ventilation with room air or supplemental oxy-
gen can have a major influence on final infarct size in mice. All tested
remote and direct IPC protocols were ineffective when using supple-
mental oxygen, despite pharmacological protection remaining effec-
tive. Ventilation strategy should be taken into consideration when
designing infarction experiments in mice. Furthermore, this variable
may potentially be important in the design of clinical studies and may
explain, in part, some of the neutral results to date. However, clinical
studies will be required to confirm the effect of ventilation on RIPC,
and these should also be designed to take into account the fact that
30–50% FiO2 is typically used during mechanical ventilation of
patients under anaesthesia.
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